Mirae Asset Global Etfs Holdings Ltd. Vir Biotechnology, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 219,160 shares of VIR stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,160Holding current value
$2.1 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VIR
# of Institutions
223Shares Held
86.3MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$160 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$123 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$48.9 Million0.0% of portfolio
-
Baillie Gifford & CO2.38MShares$22.9 Million0.01% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.27B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...